BOCA RATON, Fla., May 3 /PRNewswire-FirstCall/ -- Nabi
Biopharmaceuticals (Nasdaq: NABI) announced today that Thomas H. McLain,
chairman, chief executive officer and president, will be presenting at the
Bank of America Health Care Conference 2006 on May 16, 2006 at 11:20 am
PT/2:20 pm ET at The Four Seasons Hotel, 3960 Las Vegas Blvd., South, Las
Vegas, Nevada. Mr. McLain will present a company overview.
The presentation will be webcast live at:
http://www.veracast.com/webcasts/bas/healthcare06/id15106602.cfm
The webcast presentation will be available through June 16, 2006.
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in
powering the immune system to develop and market products that fight
serious medical conditions. The company has three products on the market
today: PhosLo(R) (calcium acetate), Nabi-HB(R) [Hepatitis B Immune Globulin
(Human)], and Aloprim(TM) (allopurinol sodium) for Injection. Nabi
Biopharmaceuticals is focused on developing products that address unmet
medical needs and offer commercial opportunities in our core business
areas: Gram-positive bacterial infections, hepatitis and transplant, kidney
disease (nephrology) and nicotine addiction. For a complete list of
pipeline products, please go to: http://www.nabi.com/pipeline/index.php .
The company is headquartered in Boca Raton, Florida. For additional
information about Nabi Biopharmaceuticals, please visit our website:
http://www.nabi.com .
SOURCE Nabi Biopharmaceuticals
 back to top
Audio:http://www.veracast.com/webcasts/bas/healthcare06/id15106602.cfm
Related links:
http://www.nabi.com
CONTACT:
Tom Rathjen, Vice President, Investor
Relations, Nabi Biopharmaceuticals, +1-561-989-5800
|
